Predict What's Next. Improve Outcomes.
OM1 (om1.com) earns a Brand Analyzer score of 82 out of 100, placing it in the Strong Brand tier among Healthcare brands, Technology brands, SaaS brands. Among 3432 Healthcare brands analyzed, OM1 ranks in the 86th percentile (category average 72, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 90/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 96/100, AI Discoverability 81/100, Brand Authority 36/100.
OM1 is a healthcare technology company that uses artificial intelligence and real-world data to help life sciences organizations and healthcare providers predict clinical outcomes, accelerate research, and improve patient care. Its patented AI foundation model is trained on billions of patient-years of real-world data and employs proprietary phenotyping technology to accelerate diagnoses, identify condition subtypes, and predict medical events, risks, and treatment responses. OM1 positions itself as a leading AI outcomes platform serving the healthcare and life sciences sectors.
| Brand Name | OM1 |
|---|---|
| Domain | om1.com |
| Industry | Healthcare, Technology |
| Main Competitors | Komodo Health (80/100), Truveta (86/100), Flatiron Health (84/100), IQVIA (85/100), Tempus (76/100), ConcertAI, Aetion, Optum (93/100) |
Moz Domain Authority 38/100 vs category average 35 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #3,372,184 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
OM1 appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "OM1 uses AI and real-world data to help life sciences and providers predict outcomes, accelerate research, and improve patient care." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js, Vercel, HubSpot.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
OM1 scores 38/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
OM1 has a weak AI-visibility profile at 38/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (31/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,372,184 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 38/100 and thin schema.org structured data. In a live check, Claude could already identify OM1 from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is OM1?", Claude could identify the brand as of August 2026. OM1 is a real-world data and outcomes analytics company focused on healthcare, using AI and machine learning to build clinical registries and measure patient outcomes across specialties like neurology, cardiology, and rheumatology. It works with life sciences companies and provid Best known for Real-world data (RWD) and outcomes-based registries powered by AI for life sciences and value-based care.
When asked "Best brands similar to OM1?", Claude would recommend OM1 as of August 2026. It's a recognized player in the real-world evidence and healthcare AI analytics space, often mentioned alongside companies like Komodo Health or Truveta.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
OM1's main competitors include Komodo Health (80/100), Truveta (86/100), Flatiron Health (84/100), IQVIA (85/100), Tempus (76/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
OM1 and Optum are competitors in Healthcare. Brand Analyzer scores OM1 at 82/100 and Optum at 93/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to OM1 include Komodo Health (80/100), Truveta (86/100), Flatiron Health (84/100), IQVIA (85/100), Tempus (76/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
OM1 has limited AI-search visibility, scoring 38/100 on Brand Analyzer's AI visibility composite (visibility 31, trust 40, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: OM1 official site
OM1 develops AI-driven tools that analyze real-world healthcare data to predict clinical outcomes, accelerate medical research, and support better patient care decisions. Its AI foundation model, trained on billions of patient-years of data, uses proprietary phenotyping technology to accelerate diagnoses, identify condition subtypes, and predict medical events, risks, and treatment responses.
Sources: OM1 official site
OM1 scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: OM1 official site
OM1 is a healthcare technology company that applies artificial intelligence and real-world data to help life sciences companies and healthcare providers predict outcomes, accelerate research, and improve patient care. It describes itself as a leading AI outcomes platform.
Sources: OM1 official site
OM1 can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: OM1 official site
OM1 offers an AI-powered outcomes platform built on a patented AI foundation model trained on real-world patient data. Its offerings include phenotyping technology to identify condition subtypes, tools to predict medical events and risks, and analytics to support accelerated diagnoses and treatment response prediction for life sciences and healthcare provider organizations.
Sources: OM1 official site
OM1 is known for its patented AI foundation model trained on billions of patient-years of real-world healthcare data, and for its proprietary phenotyping technology used to predict clinical outcomes and treatment responses for life sciences and provider organizations.
Sources: OM1 official site
OM1's platform is used by life sciences companies, healthcare providers, and healthcare leaders who seek to accelerate research, predict clinical outcomes, and improve patient care decisions using real-world data and AI.
Sources: OM1 official site
Ranked closest to OM1: Notable (82/100), NextGen Healthcare (82/100), OrbiMed (82/100), Organic India (82/100).
A step up - brands to learn from: Oura (91/100), Olay (91/100).
Category leader: Elsevier (96/100).